We are live on ! Find out more
SCP

SymBiosis Capital Partners Portfolio holdings

AUM $52.8M
This Fund
S&P 500
This Quarter Est. Return
+20.6%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$108M
Cap. Flow %
98.23%
Top 10 Hldgs %
100%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EVMN
Evommune Inc
EVMN
+$24.1M
2
VSTM icon
Verastem
VSTM
+$17.8M
3
IVA
Inventiva
IVA
+$12.1M
4
PGEN icon
Precigen
PGEN
+$11.6M
5
RANI icon
Rani Therapeutics
RANI
+$9.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 83.78%
2 Technology 12.09%
3 Consumer Staples 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVMN
1
Evommune Inc
EVMN
$506M
$21.9M 20.03%
+1,280,778
New +$24.1M
VSTM icon
2
Verastem
VSTM
$640M
$15.4M 14.1%
+2,000,000
New +$17.8M
AMPG icon
3
AmpliTech
AMPG
$107M
$13.2M 12.09%
+2,555,000
New +$8.64M
PGEN icon
4
Precigen
PGEN
$2.7B
$12.5M 11.45%
+3,000,000
New +$11.6M
IVA
5
Inventiva
IVA
$1.13B
$12.1M 11.04%
+2,600,000
New +$12.1M
NUVB icon
6
Nuvation Bio
NUVB
$2.48B
$11.2M 10.23%
+1,250,000
New +$7.74M
RANI icon
7
Rani Therapeutics
RANI
$98M
$8.51M 7.77%
+6,300,000
New +$9.5M
AARD
8
Aardvark Therapeutics
AARD
$145M
$6.26M 5.71%
+476,595
New +$5.95M
CLNN icon
9
Clene
CLNN
$55.2M
$4.52M 4.13%
+770,495
New +$6.4M
GBIO
10
DELISTED
Generation Bio
GBIO
$3.78M 3.45%
+665,000
New +$3.76M
SRZNW
11
DELISTED
Surrozen Inc Warrant
SRZNW
$3K ﹤0.01%
+150,000
New +$2.22K

Similar funds

HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
IPHI
Inflection Point Holdings II New York $47.3M AUM
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
GC
Greencape Capital Melbourne, Australia $59.9M AUM 23.92% 1-Year Est. Return
ACM
AREX Capital Management New York $60.5M AUM 45.91% 1-Year Est. Return
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM

SymBiosis Capital Partners's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for SymBiosis Capital Partners, which disclosed 11 positions worth $109M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Evommune Inc: 1,280,778 shares worth $21.9M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, followed by Technology and Consumer Staples.

  • SymBiosis Capital Partners's largest Q4 2025 buy was Evommune Inc: 1,280,778 shares worth $21.9M.
  • SymBiosis Capital Partners's ten largest holdings make up 100% of its $109M portfolio in Q4 2025.
  • SymBiosis Capital Partners disclosed 11 positions in Q4 2025, its first 13F filing on record.

Based on SymBiosis Capital Partners's 13F filing for Q4 2025, filed 12 Feb 2026.